YEM Search

搜索结果

CACNA2D1

靶点ID:TCMBANKGE009216

靶点别名:CACNA2; CACNL2A; CCHL2A; LINC01112; lncRNA-N3

靶点描述:calcium voltage-gated channel auxiliary subunit alpha2delta 1

染色体:7

染色体位置:7q21.11

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:1399

OMIM_Link:114204

Ensembl_Link:ENSG00000153956

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN004890	Isobutyryl shikonin	52438-12-7; [(1S)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 2-methylpropanoate; ZINC1702730; (1R)-1-(5,8-DIHYDROXY-1,4-DIOXONAPHTHALEN-2-YL)-4-METHYLPENT-3-EN-1-YL 2-METHYLPROPANOATE; CTK5J8655; MFCD00144512; (1r)-1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-en-1-yl 2-methylpropanoate; SCHEMBL3298557; C17414; C-56533; 2-methylpropionic acid [(1S)-1-(5,8-dihydroxy-1,4-diketo-2-naphthyl)-4-methyl-pent-3-enyl] ester; Isobutylshikonin; CHEBI:81070; AC1LA0S8; Isobutyrylshikonin; FT-0770577; [(1S)-1-(5,8-dihydroxy-1,4-dioxo-naphthalen-2-yl)-4-methyl-pent-3-enyl] 2-methylpropanoate; isobutyryl shikonin; [(1R)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 2-methylpropanoate; [(1S)-1-(5,8-dihydroxy-1,4-dioxo-2-naphthyl)-4-methyl-pent-3-enyl] 2-methylpropanoate; 2-methylpropanoic acid [(1S)-1-(5,8-dihydroxy-1,4-dioxo-2-naphthyl)-4-methylpent-3-enyl] ester; isobutyrylshikonin	C20H22O6	358.4 g/mol	CC(C)C(=O)OC(CC=C(C)C)C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O
TCMBANKIN009329	magnesium sulfate		MgSO4	120.37 g/mol	[O-]S(=O)(=O)[O-].[Mg+2]
TCMBANKIN034049	[(1R)-1-(5,8-dihydroxy-1,4-dioxo-2-naphthyl)-4-methyl-pent-3-enyl] 2-methylpropanoate	2-methylpropanoic acid [(1R)-1-(5,8-dihydroxy-1,4-dioxo-2-naphthyl)-4-methylpent-3-enyl] ester; 2-methylpropionic acid [(1R)-1-(5,8-dihydroxy-1,4-diketo-2-naphthyl)-4-methyl-pent-3-enyl] ester; [(1R)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 2-methylpropanoate; [(1R)-1-(5,8-dihydroxy-1,4-dioxo-naphthalen-2-yl)-4-methyl-pent-3-enyl] 2-methylpropanoate		358.42
TCMBANKIN035115	cubebininolide		C24H30O8	446.5 g/mol	COC1=CC(=CC(=C1OC)OC)CC2COC(=O)C2CC3=CC(=C(C(=C3)OC)OC)OC
TCMBANKIN042881	Mono-O-methylwightin	2-(2,3-dimethoxyphenyl)-5-hydroxy-7,8-dimethoxy-chromone; 2-(2,3-dimethoxyphenyl)-5-hydroxy-7,8-dimethoxychromen-4-one; 2-(2,3-Dimethoxyphenyl)-5-hydroxy-7,8-dimethoxy-4H-1-benzopyran-4-one; LMPK12111317; 2-(2,3-dimethoxyphenyl)-5-hydroxy-7,8-dimethoxy-4-chromenone; mono-o-methylwightin; AC1NSYRB; 5-hydroxy-7,8,2',3'-tetramethoxyflavone; SCHEMBL15572930; 5-Hydroxy-2',3',7,8-tetramethoxyflavone; 2-(2,3-dimethoxyphenyl)-5-hydroxy-7,8-dimethoxy-chromen-4-one	C19H18O7	358.3 g/mol	COC1=CC=CC(=C1OC)C2=CC(=O)C3=C(O2)C(=C(C=C3O)OC)OC
TCMBANKIN061864	Skullcapflavone II	CHEBI:9061; SCHEMBL3960981; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxy-; Skullcapflavon II; AC1L3Y1Y; NSC717846; skullcapflavone ii; MolPort-019-937-105; ZINC899074; AC1Q6AIS; DTXSID10203606; 5-hydroxy-2-(2-hydroxy-6-methoxy-phenyl)-6,7,8-trimethoxy-chromone; Neobaicalein; 5,2'-Dihydroxy-6,7,8,6'-tetramethoxyflavone; C10183; NP-016391; 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxy-4-chromenone; NSC-717846; 55084-08-7; CHEMBL465561; NCI60_040650; 5-hydroxy-2-(2-hydroxy-6-methoxy-phenyl)-6,7,8-trimethoxy-chromen-4-one; 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxy-4H-1-benzopyran-4-one; Skullcapflavone II, >=90% (LC/MS-UV); LMPK12111423; Scullcapflavone II; 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-6,7,8-trimethoxychromen-4-one; MCULE-5710725548	C19H18O8	374.34	COC1=CC=CC(=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000002	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Sign or Symptom	phenotype
TCMBANKDI002274	Pathological Conditions, Signs and Symptoms	-	Sign or Symptom	phenotype
TCMBANKDI002572	-	-	Finding	disease
TCMBANKDI003957	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the cardiovascular system	Sign or Symptom	phenotype
TCMBANKDI004713	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI005353	Pathological Conditions, Signs and Symptoms	-	Sign or Symptom	phenotype
TCMBANKDI008259	Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	-	Finding	phenotype
TCMBANKDI008314	Eye Diseases	-	Disease or Syndrome	disease
TCMBANKDI009702	Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	phenotype
TCMBANKDI011479	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI013839	Male Urogenital Diseases	Abnormality of the genitourinary system	Disease or Syndrome	disease
TCMBANKDI017581	-	-	Finding	phenotype
TCMBANKDI018017	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Sign or Symptom	phenotype
TCMBANKDI022421	Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases	-	Disease or Syndrome	disease
TCMBANKDI023464	Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI023791	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI023984	Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI025428	Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Stomatognathic Diseases	-	Disease or Syndrome	disease
TCMBANKDI025850	Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI026511	Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases	-	Disease or Syndrome	disease
TCMBANKDI027325	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Sign or Symptom	phenotype
TCMBANKDI027872	Cardiovascular Diseases	Abnormality of the cardiovascular system	Finding	phenotype
TCMBANKDI028487	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI030316	Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI032138	Pathological Conditions, Signs and Symptoms	-	Pathologic Function	phenotype
TCMBANKDI032143	Pathological Conditions, Signs and Symptoms	-	Sign or Symptom	phenotype